Stock Spotlight | Contemporary Amperex Technology

Contemporary Amperex Technology (3750.HK) has recently been added to the HM1 portfolio, following a recommendation from Munro Partners.

Stock Spotlight | Contemporary Amperex Technology

June 9, 2026
Contemporary Amperex Technology (3750.HK) has recently been added to the HM1 portfolio, following a recommendation from Munro Partners.
Read Transcript

Contemporary Amperex Technology (3750.HK) has recently been added to the HM1 portfolio, following a recommendation from Munro Partners.

Contemporary Amperex Technology (CATL) is the world's largest battery cell manufacturer, holding around 39% of global market share in 2025. The company operates a vertically integrated model spanning mining, processing, R&D and production. It is a key supplier to the electric vehicle (EV) industry, serving nine of the world's top 10 manufacturers, and is a leader in lithium iron phosphate (LFP) batteries, which are gaining market share due to their lower cost and stronger safety profile.

While EV volume growth may moderate in 2026, larger battery sizes per vehicle and growing demand from commercial trucks are expected to support continued growth. CATL is also expected to benefit from higher oil prices, which can accelerate the adoption of electric transport.

Munro Partners believes a compelling near-term growth opportunity is emerging in grid energy storage systems (ESS), particularly in China, where excess solar generation is often wasted due to limited storage capacity. With ambitious policies supporting rapid ESS expansion, this represents a significant opportunity for CATL, with the ESS market expected to grow by more than 50% in 2026.

The company continues to demonstrate strong execution, guiding to 20–30% volume growth over the next five years. It has also maintained stable margins despite rising lithium costs, supported by pricing mechanisms with customers. At the same time, CATL continues to advance battery innovation, including sodium-ion technology, which could further reduce costs and strengthen its competitive position over time.

Contemporary Amperex Technology (3750.HK) has recently been added to the HM1 portfolio, following a recommendation from Munro Partners.

Contemporary Amperex Technology (CATL) is the world's largest battery cell manufacturer, holding around 39% of global market share in 2025. The company operates a vertically integrated model spanning mining, processing, R&D and production. It is a key supplier to the electric vehicle (EV) industry, serving nine of the world's top 10 manufacturers, and is a leader in lithium iron phosphate (LFP) batteries, which are gaining market share due to their lower cost and stronger safety profile.

While EV volume growth may moderate in 2026, larger battery sizes per vehicle and growing demand from commercial trucks are expected to support continued growth. CATL is also expected to benefit from higher oil prices, which can accelerate the adoption of electric transport.

Munro Partners believes a compelling near-term growth opportunity is emerging in grid energy storage systems (ESS), particularly in China, where excess solar generation is often wasted due to limited storage capacity. With ambitious policies supporting rapid ESS expansion, this represents a significant opportunity for CATL, with the ESS market expected to grow by more than 50% in 2026.

The company continues to demonstrate strong execution, guiding to 20–30% volume growth over the next five years. It has also maintained stable margins despite rising lithium costs, supported by pricing mechanisms with customers. At the same time, CATL continues to advance battery innovation, including sodium-ion technology, which could further reduce costs and strengthen its competitive position over time.

Disclaimer: This material has been prepared by Hearts & Minds Investments, published on June 9, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts
October 3, 2023

Understanding the 4 pillar framework underpinning a high conviction strategy

Listen to episode one with Chief Investment Officer Charlie Lanchester and TDM Growth Partners Investment Team Members Ed Cowan and Fraser Christie. They share their unique investment philosophies and delve into two high conviction stocks recommended for the HM1 portfolio.

Read More
investing
September 5, 2023

Recap on our Australian portfolio holdings

Off the back of reporting season, we have collated some feedback from our Fund Managers on some of the Australian listed companies in the HM1 portfolio.

Read More
April 10, 2023

Introducing our new Chief Investment Officer, Charlie Lanchester

We would like to introduce our new Chief Investment Officer, Charlie Lanchester. Charlie has significant funds management experience and thrilled to be joining the HM1 team.

Read More
November 11, 2022

Sohn Hearts & Minds with Nick Griffin and Maggie O'Neill

Maggie O'Neill, HM1's Head of Marketing and Operations joined Nick Griffin, CIO of Munro Partners to discuss Hearts & Minds' history, Munro Partners' involvement and Nick's upcoming stock pitch.

Read More
July 21, 2020

Hearts and Minds but no ratings

HM1 CIO, Rory Lucas recently spoke with the Financial Standard about our 12-month performance and the challenges in receiving ratings from the major research houses.

Read More
November 14, 2018

Hearts and Minds LIC starts trading on ASX after strong support

Media Release: HM1 starts trading on the ASX after closing its $500 million IPO early and bringing forward the company's listing date.

Read More
November 13, 2018

Hearts and Minds: Aiming to make a positive impact

Millennials are leading a global investment revolution, driving a change in how the super-rich invest their money. Ethical and sustainable investing is booming and poised to accelerate.

Read More
October 22, 2018

Charitable LIC reaches offer target early – Close of General Offer

HM1, a new listed investment company with performance and charitable goals, has closed its general offer early following strong market support.

Read More
October 15, 2018

Win-Win for investors and charities as top funds join forces for good

Australia’s top fund managers have joined forces in the name of medical research and today announce the opening of the IPO for Hearts and Minds Investments Limited.

Read More